47 related articles for article (PubMed ID: 1564606)
1. National cooperative rHu erythropoietin study in patients with chronic renal failure: a phase IV multicenter study. Report of National Cooperative rHu Erythropoietin Study Group.
Nissenson AR
Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):24-33. PubMed ID: 1928075
[TBL] [Abstract][Full Text] [Related]
2. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure.
Cowgill LD; James KM; Levy JK; Browne JK; Miller A; Lobingier RT; Egrie JC
J Am Vet Med Assoc; 1998 Feb; 212(4):521-8. PubMed ID: 9491159
[TBL] [Abstract][Full Text] [Related]
3. Review of patients' responses to epoetin alfa therapy.
Krantz SB
Pharmacotherapy; 1990; 10(2 ( Pt 2)):15S-21S. PubMed ID: 2189124
[TBL] [Abstract][Full Text] [Related]
4. Use of EPOGEN for treatment of anemia associated with chronic renal failure.
Erlich L
Crit Care Nurs Clin North Am; 1990 Mar; 2(1):101-13. PubMed ID: 2357306
[TBL] [Abstract][Full Text] [Related]
5. Clinical administration of epoetin alfa recombinant.
Taylor BA; Weinstein SM
J Intraven Nurs; 1992; 15(2):78-82. PubMed ID: 1564606
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin 1991--an overview.
Eschbach JW
Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):3-9. PubMed ID: 1928076
[TBL] [Abstract][Full Text] [Related]
7. Epoetin: human recombinant erythropoietin.
Flaharty KK; Grimm AM; Vlasses PH
Clin Pharm; 1989 Nov; 8(11):769-82. PubMed ID: 2680241
[TBL] [Abstract][Full Text] [Related]
8. Management of blood pressure changes during recombinant human erythropoietin therapy.
Levin N
Semin Nephrol; 1989 Mar; 9(1 Suppl 2):16-20. PubMed ID: 2669081
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin, the biology of erythropoiesis and epoetin alfa. An overview.
Bieber E
J Reprod Med; 2001 May; 46(5 Suppl):521-30. PubMed ID: 11396386
[TBL] [Abstract][Full Text] [Related]
10. Monitoring considerations in recombinant human erythropoietin therapy.
Ogden DA
Semin Nephrol; 1989 Mar; 9(1 Suppl 2):12-5. PubMed ID: 2669080
[TBL] [Abstract][Full Text] [Related]
11. Resistance to recombinant human erythropoietin therapy: a real clinical entity?
Stivelman JC
Semin Nephrol; 1989 Mar; 9(1 Suppl 2):8-11. PubMed ID: 2669085
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
